A Phase I study with parallel group comparison of seven ascending doses of B22956/1 with placebo, to assess safety, tolerability and preliminary contrast efficacy for magnetic resonance imaging in healthy male volunteers.

Study B22956

Projektbeginn: 23.02.2000
Projektende: 31.03.2003

Hennig J, Langer M, Maier-Lenz H.

Albert-Ludwigs-Universität Freiburg
Department für Radiologische Diagnostik und Therapie
Klinik für Radiologie
Hugstetterstrasse 55
79106 Freiburg

Telefon: +49-761-270-38050/38060
Fax: +49-761-270-38380

• Bracco s.p.a., Milano, Italy

Bracco-Studie